Literature DB >> 1271835

Systemic hypertension following myocardial revascularization. A method of treatment using epidural anesthesia.

P F Hoar, R F Hickey, D J Ullyot.   

Abstract

Seven of 12 patients (58%) undergoing myocardial revascularization surgery became hypertensive in the immediate postoperative period. The hypertensive patients had significant elevations in peripheral vascular resistance (22.0 +/- 2.0 S.E. resistance units) compared to measurements in normotensive patients (15.6 +/- 1.3 S.E. resistance units) (p less than 0.05), whereas the heart rates and cardiac indices were similar. Administration of thoracic epidural anesthesia to postoperatively hypertensive patients lowered systemic arterial pressure by decreasing peripheral vascular resistance (p less than 0.005) but not affecting the pulse rate and cardiac index. The ratio diastolic pressure-time index/systemic pressure-time index (DPTI/SPTI), an indirect measurement of subendocardial oxygenation, increased from preanesthetic values of 0.80 +/- 0.08 S.E. to 1.09 +/- 0.09 S.E. (p less than 0.025) after the systemic arterial pressure was lowered in postoperatively hypertensive patients. Hypertensive episodes following myocardial revascularization procedures appear related to increased alpha-adrenergic activity, which products elevation in peripheral vascular resistance. Decreasing peripheral vascular resistance by chemical sympathectomy with thoracic epidural anesthesia lowers the systemic arterial pressure and improves the DPTI/SPTI ratio.

Entities:  

Mesh:

Year:  1976        PMID: 1271835

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Arterial hypertension following coronary artery surgery: influence of the narcotic agent used for anaesthesia.

Authors:  J F Hardy; M Boulanger; J G Maillé; B Paiement; J Taillefer; P Sahab; M Delorme
Journal:  Can Anaesth Soc J       Date:  1983-07

2.  Factors relating to the development of hypertension after cardiopulmonary bypass.

Authors:  T J Cooper; T H Clutton-Brock; S N Jones; J Tinker; T Treasure
Journal:  Br Heart J       Date:  1985-07

3.  Hypertension following coronary artery bypass graft.

Authors:  W McIlvaine; M Boulanger; J G Maillé; B Paiement; J Taillefer; P Sahab
Journal:  Can Anaesth Soc J       Date:  1982-05

4.  Role of renin-angiotensin system in cardiopulmonary bypass hypertension.

Authors:  G E Townsend; J E Wynands; D G Whalley; P Wong; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1984-03

5.  Does propranolol alter the vascular response to phenylephrine before or during halothane anaesthesia in patients with coronary artery disease?

Authors:  D F Grum; S S Azmy
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063

6.  Nifedipine for postoperative blood pressure control following coronary artery vein grafts.

Authors:  V S Iyer; W J Russell
Journal:  Ann R Coll Surg Engl       Date:  1986-03       Impact factor: 1.891

7.  Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients.

Authors:  K M Taylor; W H Bain; K G Davidson; M A Turner
Journal:  Thorax       Date:  1982-05       Impact factor: 9.139

8.  Pathophysiology of hypertension following coronary artery bypass surgery: an experimental dog model for postoperative hypertension.

Authors:  E Yamanouchi; H Maeta; M Hori
Journal:  Heart Vessels       Date:  1985-11       Impact factor: 2.037

9.  Peripheral vascular resistance and angiotensin II levels during pulsatile and non-pulsatile cardiopulmonary bypass.

Authors:  K M Taylor; W H Bain; M Russell; J J Brannan; I J Morton
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

10.  Incidence of epidural haematoma and neurological injury in cardiovascular patients with epidural analgesia/anaesthesia: systematic review and meta-analysis.

Authors:  Wilhelm Ruppen; Sheena Derry; Henry J McQuay; R Andrew Moore
Journal:  BMC Anesthesiol       Date:  2006-09-12       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.